Sgsh Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Sgsh Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SGSH (N-Sulfoglucosamine Sulfohydrolase) is a gene that encodes the enzyme sulfamidase, which is essential for the degradation of heparan sulfate in lysosomes. Mutations cause Sanfilippo syndrome type B.
Sgsh Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Sgsh Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SGSH (N-Sulfoglucosamine Sulfohydrolase) is a gene that encodes the enzyme sulfamidase, which is essential for the degradation of heparan sulfate in lysosomes. Mutations cause Sanfilippo syndrome type B.
Gene Overview
Function
SGSH encodes sulfamidase (N-sulfoglucosamine sulfohydrolase), a lysosomal enzyme that catalyzes the removal of N-linked sulfate groups from heparan sulfate:
Substrate: N-sulfoglucosamine residues in heparan sulfate chains
Coarse facial features (milder than other MPS types)
Hearing loss
Vision problems
Recurrent infections
Pathogenesis
Enzyme deficiency causes heparan sulfate accumulation in lysosomes
Disrupts cellular function in [neurons](/entities/neurons) and other tissues
Progressive neurodegeneration is the hallmark
Genotype-Phenotype Correlations
Certain mutations (e.g., p.R74C, p.R245H) associated with milder phenotypes
Null mutations associated with severe early-onset disease
Expression
SGSH is expressed in:
Brain (neurons, astrocytes)
Liver
Kidney
Fibroblasts
Most tissues
Therapeutic Implications
Enzyme Replacement Therapy (ERT)
Investigational (IV and intrathecal delivery)
Challenges: crossing the [blood-brain barrier](/entities/blood-brain-barrier)
Gene Therapy
AAV vectors in clinical trials
Shows promise for neurological symptoms
Substrate Reduction Therapy
Targeting glycosaminoglycan synthesis
Hematopoietic Stem Cell Transplantation
Mixed results for neurological outcomes
See Also
[Genes/Sgsh](/genes/sgsh) — This page
Overview
Sgsh Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Sgsh Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
Yogalingam et al. (2002). "Molecular analysis of the mucopolysaccharidosis type IIIB gene." Human Mutation. [DOI:10.1002/humu.9055](https://doi.org/10.1002/humu.9055)
Canals et al. (2021). "Gene therapy for Sanfilippo B syndrome: preclinical evaluation." Molecular Therapy. [DOI:10.1016/j.ymthe.2021.03.019](https://doi.org/10.1016/j.ymthe.2021.03.019)